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Abstract
The mitotic spindle assembly checkpoint (SAC) is an intricate cell signal-
ing system that ensures the high fidelity and timely segregation of chromo-
somes during cell division.Mistakes in this process can lead to the loss, gain,
or rearrangement of the genetic material. Gross chromosomal aberrations
are usually lethal but can cause birth and development defects as well as
cancer. Despite advances in the identification of SAC protein components,
important details of the interactions underpinning chromosome segregation
regulation remain to be established. This review discusses the current un-
derstanding of the function, structure, mode of regulation, and dynamics of
the assembly and disassembly of SAC subcomplexes, which ultimately safe-
guard the accurate transmission of a stable genome to descendants.We also
discuss how diverse oncoviruses take control of human cell division by ex-
ploiting the SAC and the potential of this signaling circuitry as a pool of
drug targets to develop effective cancer therapies.
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Spindle assembly
checkpoint (SAC):
an evolutionarily
conserved regulatory
mechanism of higher
organisms that
monitors and corrects
chromosome
segregation defects
upon cell division
Chromosomal
passenger complex
(CPC): a complex
constituted by aurora
B kinase, borealin, the
inner centromere
protein (INCENP),
and survivin that acts
as a master regulator
of mitosis
Mitotic checkpoint
complex (MCC): the
assembly constituted
by BUBR1, BUB3,
CDC20, and MAD2
that acts as an inhibitor
of the APC/C
Anaphase-promoting
complex/cyclosome
(APC/C):
a multiprotein E3
ubiquitin ligase for
which substrate
selection is driven
through binding of
one of two protein
cofactors (CDH1 and
CDC20) in a cell
cycle–dependent
manner
Pseudokinase: a
protein that adopts the
canonical kinase fold
but lacks one or more
of the amino acids
required to
phosphorylate protein
substrates
1. INTRODUCTION
1.1. A Brief History of the Mitotic SAC
The exquisite regulation of the mitotic spindle assembly checkpoint (SAC) is a fine example of
how the remodeling of protein complexes in time and space has evolved as an effective strategy
to increase selectivity of signals in the cell with a minimal margin for error. Mistakes in the pro-
cess of cell division can lead to the rearrangement, loss, or gain of chromosomes (aneuploidy);
genome instability; and cancer. SAC signaling requires communication with the kinetochore, a
large macromolecular assembly that acts as the site for attachment of chromosomes to micro-
tubule polymers that pull sister chromatids apart during cell division (Figure 1). A critical aspect
of SAC signaling is that connection of the centromere to microtubules of the mitotic spindle by
the kinetochore must be strong enough to sustain the pulling forces during anaphase, whereas it
must also be sufficiently dynamic to ensure proper chromosome alignments at themetaphase plate.
This is coordinated through a sophisticated network of protein-DNA and protein-protein interac-
tions. Different biochemical and mechanical models of the formation of SAC protein assemblies
in response to spindle attachment defects have been proposed. On the one hand, biochemical-
oriented models postulate that sensing and signal initiation relies on binding competition between
SAC and spindle proteins for microtubule binding sites at the kinetochore (Hiruma et al. 2015, Ji
et al. 2015). On the other hand, mechanical models postulate that proteins in close proximity to
each other in unattached kinetochores define a mechanical switch for chromosome-microtubule
attachment sensing and signal initiation, where protein separation after attachment silences the
signal (Aravamudhan et al. 2015). More recently, a new model of SAC signaling initiation that
integrates biochemical and mechanical principles has been proposed ( Joglekar & Aravamudhan
2016). Considerable progress has been made in understanding the composition of the SAC and
the recruitment hierarchy of its components [recent excellent revisions of this fascinating topic
have been reported (Dou et al. 2019, Gelens et al. 2018, Pesenti et al. 2016, Saurin 2018)]. How-
ever, important aspects of SAC initiation and its regulation have proved elusive even though they
are clearly indispensable for a deeper understanding of the control of chromosome segregation
and a prerequisite to envisage new ways to manipulate SAC signaling for the treatment of cancer.
1.2. The Central SAC Protein Components
Central protein components of the SAC harbor specific protein motifs and domains that dic-
tate protein functionality and stability (Figure 2). For instance, BUB1 (budding uninhibited by
benzimidazoles 1), BUBR1 (BUB-related 1), MPS1 (monopolar spindle 1), PLK1 (polo kinase
1), and aurora B are all multidomain serine/threonine protein kinases with essential roles in the
SAC. BUB1 is required for the proper assembly of the inner centromere (Boyarchuk et al. 2007)
and recruitment of the chromosomal passenger complex (CPC) and SGO1 (shugoshin 1) to the
centromere. Moreover, BUB1 kinase activity is important for the establishment and maintenance
of productive attachment to spindle microtubules (Elowe 2011). BUBR1, together with BUB3
(budding uninhibited by benzimidazoles 3), MAD2 (mitotic arrest deficient 2), and CDC20 (cell
division cycle 20), forms part of the mitotic checkpoint complex (MCC), which is assembled in
response to improper chromosome attachment to the mitotic spindle to inhibit the anaphase-
promoting complex/cyclosome (APC/C) (Barford 2011, Foe &Toczyski 2011,Herzog et al. 2009,
Yamano 2019, G. Zhang et al. 2016). At least in mitosis, BUBR1 functions as a pseudokinase that
plays important roles in chromosome segregation, DNA repair, ciliogenesis, and neuron differ-
entiation (Bolanos-Garcia & Blundell 2011). PLK1 is a mitotic protein kinase that contributes to
mitotic entry, bipolar spindle formation, and the establishment of stable kinetochore-microtubule
258 Curtis et al.
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Figure 1
Basis of SAC activation and inactivation during mitosis. (a) Unattached kinetochores catalyze recruitment of SAC proteins. MAD2
binds BUBR1, BUB3, and CDC20, forming the MCC, which subsequently inhibits the APC/C. Cells are arrested in mitosis as a result
of APC/C inhibition until all chromosomes are accurately attached to microtubule spindles. (b) When this ensues, the MCC
disassembles, allowing CDC20 to bind and activate the APC/C, resulting in the ubiquitination and subsequent degradation of the
APC/C targets securin and cyclin B1. Degradation of securin releases the protease separase, which cleaves its specific substrate cohesin,
enabling sister chromatids to separate, while the timely degradation of cyclin B1 by the proteasome inactivates CDK1, driving mitotic
exit. Abbreviations: APC/C, anaphase-promoting complex/cyclosome; MCC, mitotic checkpoint complex; SAC, spindle assembly
checkpoint.
attachments (Lenart et al. 2007, Liu et al. 2012, Steegmaier et al. 2007, von Schubert et al. 2015).
PLK1 localizes to kinetochores by interacting with several kinetochore proteins (Amin et al. 2014,
Qi et al. 2006) and is also involved in the maintenance of SAC activity through its physical inter-
action with BUB1, which supports BUB1 localization to the kinetochore and the phosphorylation
of MPS1 and KNL1 (kinetochore scaffold 1) (Ikeda & Tanaka 2017). When PLK1 is depleted
or inhibited, cells arrest in mitosis due to SAC activation by defective kinetochore-microtubule
attachments (Lenart et al. 2007, Steegmaier et al. 2007). MPS1 (also known as TTK) is the
most upstream regulator of the SAC signaling pathway (Pachis & Kops 2018, Saurin 2018). The
www.annualreviews.org • Chromosome Segregation Defects and Cancer 259
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Figure 2
A simplified view of the functional domains and motifs of the central SAC protein components. The
highlighted functional modules mediate the various catalytic (kinase activity) or specific protein recognition
functions of the SAC proteins, whereas degrons such as the KEN box and D box motifs are responsible for
their timely degradation throughout mitosis. For simplicity, other functional motifs such as the ABBA motif
and KI motif of BUB1 and BUBR1 are not shown. Abbreviations: D, destruction; KEN, lysine-glutamate-
asparagine; KI, lysine-isoleucine; SAC, spindle assembly checkpoint.
phosphorylation consensus sequence of MPS1 seems to be similar to that of PLK1 (Dou et al.
2011): MPS1 phosphorylates the kinetochore organizer protein KNL1, a posttranslational mod-
ification that promotes the recruitment of the SAC proteins BUB1, BUBR1, and BUB3 to
the kinetochore ( Ji et al. 2017, Primorac et al. 2013, Vleugel et al. 2015, Zhang et al. 2014).
Aurora B phosphorylates substrates at the kinetochore to inhibit microtubule attachment, includ-
ing NDC80, which is the principal microtubule attachment complex at kinetochores (Cheeseman
et al. 2006, Ciferri et al. 2008, Cordeiro et al. 2018, Wei et al. 2007).
BUB1 and BUBR1 share a common architecture: a conserved N-terminal domain, a middle
nonconserved domain that contains the binding region for the mitotic checkpoint protein BUB3,
and a C-terminal serine/threonine kinase domain. The N-terminal regions of BUB1 and BUBR1
(and also MPS1) contain a divergent arrangement of the TPR (tetratricopeptide repeat) motif
(Bolanos-Garcia et al. 2009, D’Arcy et al. 2010, Lee et al. 2012) that mediates recruitment of the
proteins to the kinetochore (Bolanos-Garcia et al. 2011; Krenn et al. 2012, 2014; Marquardt et al.
2016; Nijenhuis et al. 2013; Thebault et al. 2012). The middle domain of BUB1 and BUBR1
contains the GLE2p-binding sequence (GLEBS)-like motif, which is located within the region
260 Curtis et al.
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E3 ubiquitin ligase:
a class of enzymes that
catalyze the final step
of ubiquitination,
namely, the transfer of
ubiquitin from an E2
ubiquitin–conjugating
enzyme to a protein
substrate
implicated in BUB3 binding. In BUB1 and MPS1, the C-terminal domain contains a catalytically
active kinase domain, whereas in BUBR1, the equivalent region harbors a domain that, at least in
the SAC, acts as a pseudokinase (Suijkerbuijk et al. 2012a, Tomoni et al. 2019).
In addition to its role as an MCC component, BUB3 binds the GLEBS motif of BUB1 and
BUBR1 (Figure 2), resulting in at least two tightly bound, constitutive protein subcomplexes
throughout the cell cycle: BUB3-BUB1 and BUB3-BUBR1. It seems that the GLEBS-mediated
interaction with BUB1 and BUBR1 is crucial for the recruitment of the later protein kinases to
the kinetochore in a process that involves the recognition of KNL1MELT-phosphorylated motifs
by MPS1 (Faesen &Musacchio 2015; Ghongane et al. 2014; Overlack et al. 2015; Primorac et al.
2013; Vleugel et al. 2013, 2015). However, other KNL1 residues that define the lysine-isoleucine
motifs also contribute to BUB1 and BUBR1 recruitment to the kinetochore (Bolanos-Garcia et al.
2011, Krenn et al. 2012, S. Zhang et al. 2016).
MAD1 (mitotic arrest deficient 1) is a 718-residue coiled-coil protein (Figure 2), the depletion
of which severely affects proper SAC signaling in mammalian cells (Luo et al. 2018).MAD1 forms
a stable complex with MAD2 in vitro (De Antoni et al. 2005, Fava et al. 2011, Ji et al. 2018,
Yu 2006). Disruption of one MAD2 gene allele causes enhanced rates of chromosome loss and
impaired checkpoint function and tumorigenesis (Michel et al. 2001).Mad2 overexpression results
in an overactive mitotic checkpoint where cells show a much more aggressive and wider range of
tumors compared to mice with lowMad2 levels.MAD2 exhibits the distinctive HORMA (HOP1,
REV7, and MAD2) domain (Figure 2).
CDC20 constitutes the target of the branch of the spindle checkpoint that monitors kineto-
chore behavior via its direct interaction with BUBR1 (Diaz-Martinez et al. 2015, Han et al. 2013,
Lischetti et al. 2014). CDC20 is largely organized in a N-terminal region of low structural com-
plexity and a single domain that defines the WD40 fold (Larsen et al. 2007). The N-terminal
disordered region contains C box, KEN box, and CRY box motifs, whereas the C-terminal tail
proceeding the WD40 domain contains an isoleucine-arginine (IR) motif (Figure 2). Both the
C box and the IR motif mediate CDC20 binding to the APC/C complex (S. Zhang et al. 2016),
the ultimate effector of cell cycle progression from metaphase to anaphase (Alfieri et al. 2017,
Watson et al. 2019). APC/C is an E3 ubiquitin ligase with its activity tightly regulated by multiple
mechanisms including acetylation, phosphorylation, the binding of inhibitors, subcellular local-
ization, and destabilization of its activators or acetylation of its component subunits (Craney et al.
2016, Hein et al. 2017, Höckner et al. 2016, Touati et al. 2018). Tight regulation of cell cycle pro-
gression by the APC/C requires its physical and sequential interaction with its two coactivators,
CDH1 (CDC20 homolog 1) and CDC20, which form the APC/C-CDH1 and APC/C-CDC20
complexes, respectively. Essentially, the APC/C-CDH1 complex is primarily active during the end
of mitotic exit and early G1 phase of the cell cycle, whereas the APC/C-CDC20 complex regulates
the transition from metaphase to anaphase and mitotic exit.
2. SAC SIGNALING RELIES ON TRANSIENT COMPLEXES
Earlier molecular details of the dynamic nature of the network of interactions underpinning SAC
signaling came from the crystal and nuclear magnetic resonance structures of members of the
MAD protein family. For instance, the structure of the MAD1-MAD2 complex revealed a so-
called safety belt mechanism underlying the regulation of the interactions betweenMAD2-MAD1
and MAD2-CDC20 (Luo et al. 2002, Sironi et al. 2002, Skinner et al. 2008, Zhang & Nilsson
2018), where a large conformational rearrangement of MAD2 from an open to a closed con-
formation acts as the rate-limiting step in cells mounting an SAC response (De Antoni et al.
2005).
www.annualreviews.org • Chromosome Segregation Defects and Cancer 261
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MPS1 activity is highly dynamic on kinetochores and its activation involves autophospho-
rylation (Kang et al. 2007, Mattison et al. 2007). Activated MPS1 promotes the association of
SAC protein components on unattached kinetochores by phosphorylating the kinetochore pro-
teinKNL1 at theMELT repeats, a posttranslationalmodification that is required for BUB1-BUB3
recruitment to the kinetochore. This is followed by recruitment of other SAC components such
as BUBR1, MAD1, and MAD2. SAC signaling is antagonized by the protein p31comet (Yang et al.
2007), which binds to the same MAD2 and BUBR1 interface, implying that there is competi-
tion between p31comet and BUBR1 to bind MAD2 (Fava et al. 2011,Mapelli et al. 2006, Yang et al.
2007). An additional layer of regulation of the p31comet-MAD2 interaction is conferred by p31comet
phosphorylation (Date et al. 2014).
In addition to KNL1, the MIS12 and NDC80 complexes define the KMN (KNL1/MIS12/
NDC80) network, a multiprotein macromolecular assembly that is essential to organize correct
kinetochore-microtubule attachments (Aravamudhan et al. 2015). Although the assembly of the
kinetochore is a crucial event in cell division, the precise sequence of events underlying the pro-
cess remains obscure. KNL1 integrates SAC kinase and phosphatase activities and contributes to
the formation of kinetochore-microtubule attachments (Przewloka & Glover 2009). In the hu-
man, the MIS12 complex (also known as the MIND complex) consists of the proteins MIS12,
DSN1,NNF1, and NSL1, the last of which links together the MIS12 and the NDC80 complexes
(Petrovic et al. 2010). This interaction enhances the binding of the NDC80 complex to micro-
tubules (Kudalkar et al. 2015). The NDC80 subcomplex is composed of four subunits: NDC80
(the subunit that gives its name to the entire subcomplex), NUF2, SPC24, and SPC25 (Ciferri
et al. 2008, Wan et al. 2009, Wei et al. 2007). The association of the SPC24-SPC25 heterodimer
is required for NDC80 binding to both the KNL1 and the MIS12 complex, while the forma-
tion of the NUF2-NDC80 assembly is required for NDC80 complex binding to microtubules
(Cheeseman et al. 2006, Ciferri et al. 2008, Joglekar & DeLuca 2009, Kiyomitsu et al. 2007,Wan
et al. 2009, Wei et al. 2007). We have argued that multiprotein complexes that assemble coop-
eratively are less likely to be formed fortuitously (Bolanos-Garcia et al. 2012). The cooperative
association of SAC signaling complexes resulting from binary interactions supports this notion, as
the interactions have proved to be specific and of low affinity, enabling the amplification of specific
signals to mount an effective SAC response.
3. POSTTRANSLATIONAL MODIFICATIONS FINE-TUNE THE SAC
In addition to the specific functions of SAC protein components conferred by the motifs and do-
mains depicted in Figure 2, additional layers of SAC regulation rely on diverse posttranslational
modifications. The concerted phosphorylation, acetylation, and ubiquitination of specific SAC
protein components greatly affects their stability, and their coordinated assembly/disassembly
into protein subcomplexes ultimately ensures the proper segregation of the chromosome upon
cell division. For instance, in prometaphase BUBR1 is acetylated by the histone acetyltransferase
PCAF (P300/CBP-associated factor) at the BUBR1 residue K250, a posttranslational modifica-
tion that is important to protect BUBR1 degradation by APC/C-CDC20 (Choi et al. 2009). Once
the checkpoint is satisfied by the proper attachment of microtubules to the kinetochores, BUBR1
is deacetylated and becomes a substrate of APC/C-CDC20-dependent proteolysis. Thus, coordi-
nated BUBR1 acetylation/deacetylation operates as a molecular switch that regulates the conver-
sion of BUBR1 from an inhibitor of the APC/C complex to its substrate. Furthermore, BUBR1
amino acid residue K668 seems to be acetylated by the acetyltransferase CBP and deacetylated
by SIRT2 (North et al. 2014). Unlike the acetylation of BUBR1 K250, acetylation at K668 in
262 Curtis et al.
A
nn
u.
 R
ev
. C
an
ce
r 
B
io
l. 
20
20
.4
:2
57
-2
78
. D
ow
nl
oa
de
d 
fr
om
 w
w
w
.a
nn
ua
lr
ev
ie
w
s.
or
g
 A
cc
es
s 
pr
ov
id
ed
 b
y 
88
.1
06
.2
11
.4
1 
on
 0
9/
07
/2
0.
 S
ee
 c
op
yr
ig
ht
 f
or
 a
pp
ro
ve
d 
us
e.
 
CA04CH14_Bolanos-Garcia ARjats.cls February 5, 2020 14:19
Degrons: specific
amino acid sequences
or structural motifs
that regulate protein
degradation rates;
some SAC proteins
contain multiple
degrons
APC/C APC/C -MCCMCC
CDC20
CDC20
CDC20
CDC20
MAD2
MAD2
BUBR1
BUBR1
MCC binds
to the APC/C
Resulting in
APC/C
inhibition
Figure 3
Structural details of the MCC-APC/C interaction. The MCC exists in a free state and in complex with the APC/C. The MCC binds
and inhibits CDC20-dependent activation of the APC/C, forming a larger assembly that contains two copies of CDC20. The loading
of CDC20 onto APC/C is regulated through APC/C phosphorylation by CDK1. Fine-tuned cycles of controlled CDC20 synthesis and
degradation confer further regulation to APC/C activity and, therefore, to mitosis progression, in response to the status of the mitotic
spindle. Abbreviations: APC/C, anaphase-promoting complex/cyclosome; MCC, mitotic checkpoint complex.
BUBR1 promotes the ubiquitination and degradation of BUBR1, providing further evidence of
the exquisite regulation of the SAC.
Tight regulation of SAC components also involves complex phosphorylation and dephospho-
rylation cascades (Bajaj et al. 2018, Faesen et al. 2017, Foss et al. 2016, Gelens et al. 2018, Ikeda
& Tanaka 2017, Jia et al. 2016, Manic et al. 2017, Moura et al. 2017). BUBR1 undergoes auto-
phosphorylation when the SAC is unsatisfied and is the substrate of PLK1 and CDK1 (cyclin-
dependent kinase 1) (Combes et al. 2017, Elowe et al. 2007, Suijkerbuijk et al. 2012b, Wong &
Fang 2007). In prophase, phosphorylation of APC/C byCDK1 kinase primes this ubiquitin E3 lig-
ase to preferentially bind the coactivator CDC20 to form an APC/C-CDC20 complex (Figure 3).
Six CDC20 residues are phosphorylated in vitro by BUB1, but not by BUBR1, MAPK, or sev-
eral other kinases (Ge et al. 2009, Tang et al. 2001, G. Zhang et al. 2016). The mutation of such
CDC20 phosphorylation sites to alanine results in reduced checkpoint arrest in mitosis. Phospho-
rylation of CDC20 by PLK1 is important for the ubiquitination and destruction of CDC20 and
impairs the CDC20-dependent activation of UBE2S by APC/C. The inhibitory phosphorylation
on CDC20 is released by kinetochore-bound PP2AB56 phosphatase. PP2AB56 is recruited to the
kinetochore by BUBR1, and a single mutation in CDC20 (D464R) disrupts binding to BUBR1,
thus impairing the dephosphorylation of CDC20 by PP2AB56. Further control of CDC20 func-
tions are provided by the KEN and the CRY boxes, which act as two independent degrons. APC/C
ubiquitin ligase activity is modulated through conformational changes that disrupt the architec-
ture of the substrate-binding site (Herzog et al. 2009), a mode of regulation that closely resembles
the regulation of protein kinases. For instance, recruitment of theMCC to APC/C-CDC20 blocks
access to the APC/C substrate binding site, thus acting as an allosteric regulator of this ubiqui-
tin E3 ligase (Figure 3). Concerted conformational changes of the CDC20-MCC complex and
the APC/C regulate the UBE2C-dependent ubiquitination of CDC20 bound to the MCC, en-
abling an exquisite control of the process that monitors and corrects chromosome segregation
errors upon cell division (Fujimitsu et al. 2016, G. Zhang et al. 2016). In summary, control of
APC/C-CDC20 activity in response to the status of the mitotic spindle involves tuneable cycles
www.annualreviews.org • Chromosome Segregation Defects and Cancer 263
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Biallelic: pertaining
to both alleles (both
alternative forms of a
gene) of a single gene
(paternal and
maternal)
of CDC20 synthesis and degradation, MCC assembly and disassembly, and the coordinated asso-
ciation/dissociation of the MCC with the APC/C-CDC20 complex.
4. SAC AND CANCER
4.1. SAC Misregulation
Aneuploidy is a common characteristic among cancer cells. Deletions, insertions, and point and
silent mutations that are associated with aneuploidy, chromosome instability (CIN), and cancer
occur throughout the BUB1 and BUBR1 gene sequences. A role for BUB1 in oncogenesis is sug-
gested by the occurrence of BUB1 mutations, differential BUB1 gene expression, and BUB1 pro-
tein levels in cancer tissues and cell lines (Piao et al. 2019, Pinto et al. 2008, Ricke et al. 2011,
Wada et al. 2008), as well as the formation of spontaneous cancers in transgenic mice that express
a dominant interfering fragment of BUB1 (Cowley et al. 2005). An oncogenic role for BUBR1
abnormal expression levels, which often results in aneuploidy and gastric cancer progression, is
also well documented (Bolanos-Garcia & Blundell 2011, Chen et al. 2015, Kawakubo et al. 2018,
Lira et al. 2010). Furthermore, BUBR1 truncating and missense mutations have been identified
in families with mosaic-variegated aneuploidy (MVA), a syndrome characterized by growth and
mental retardation and microcephaly (Hanks et al. 2004, Ochiai et al. 2014, Simmons et al. 2019).
The MVA biallelic mutations have provided important insights into cancer development, as these
mutations were the first to relate germline mutations in a spindle checkpoint gene with a human
disorder (Hanks et al. 2004). Nearly 50% of the BUB1 amino acid substitutions associated with
cancer can bemapped onto regions predicted to bemostly disordered, suggesting that substitution
of these residues impairs specific protein-protein interactions that are critical for SAC signaling.
Compared to the BUB1 gene, a larger number of BUBR1 mutations associated with cancer have
been reported to date. Like with BUB1, the majority of BUBR1 amino acid residue substitutions
that are associated with different classes of cancer can be mapped onto regions of predicted low
structural complexity (Bolanos-Garcia & Blundell 2011). The mutations that are mapped onto
the kinase domain are the second most frequent followed by those located in the kinetochore-
binding region. Although studies on BUB1 and BUBR1 mutants suggest that cancer formation
is linked to a weakened SAC, the precise roles of these mutants in tumor formation remain
unclear.
MPS1 has been identified in the signature of the top 25 genes overexpressed in CIN and
aneuploid tumors (Carter et al. 2006, Kops et al. 2005) and is upregulated in several tumors
of different origins including bladder, anaplastic thyroid, breast, lung, esophagus, and prostate.
MPS1 protein levels and kinase activity peak upon spindle checkpoint activation. However, ab-
normally high and lowMPS1 levels cause aneuploidy and SAC signaling defects. Similar to BUB1,
BUBR1, and MPS1, abnormal levels of BUB3, MAD1, MAD2, and CDC20 are significantly el-
evated in diverse cancer tissues (details of this are presented in Supplemental Tables 1–7). The
relative level of CDC20 overexpression is associated with an aggressive course of breast cancer
and is correlated with extremely poor outcomes (Karra et al. 2014). CDC20 is also highly ex-
pressed in certain lung cancers and associated with pleural invasion (Kato et al. 2012), whereas
suppression of its expression not only in such tumors but also in hepatocellular carcinoma cells
inhibited cell growth, induced G2/M cell cycle arrest, and retarded colony formation (Li et al.
2014). CDC20 overexpression has also been reported in gastric and pancreatic cancer and pos-
itively associated with tumor size, histological grade, and lymph node metastasis (Chang et al.
2012, Taniguchi et al. 2008). Because of its association with clinical stage, CDC20 has been pro-
posed as a prognostic biomarker of human non-small-cell lung and colorectal cancer (Kato et al.
2012).
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Figure 4
Manipulation of the SAC by oncoviruses. (a) HTLV-1 Tax binds MAD1, causing loss of the MCC, and (b) interacts with and
prematurely activates the APC/C, subsequently inducing aneuploidy. (c) KSHV LANA associates with the APC/C, inducing BUB1
recruitment to the APC/C for subsequent ubiquitination and degradation, which impedes SAC activity. (d) SV40 LT binds BUB1,
disrupting the SAC. Abbreviations: APC/C, anaphase-promoting complex/cyclosome; HTLV-1, human T cell lymphotropic virus type
1; KSHV, Kaposi’s sarcoma–associated herpesvirus; LANA, latency-associated nuclear antigen; LT, large tumor antigen; MCC, mitotic
checkpoint complex; SAC, spindle assembly checkpoint; SV40, simian virus 40.
4.2. The SAC is a Target for Oncoviruses
Diverse types of oncoviruses manipulate the host cell cycle during infection, making the SAC
an attractive target for establishing an intracellular environment favoring viral replication and
inducing chromosomal missegregation with subsequent tumorigenesis (Figures 4, 5, and 6). For
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Manipulation of the SAC by oncoviruses. (a) Ad E4orf4 in complex with PP2A manipulates the APC/C, causing a mitotic block in
G2/M phase. (b) HBVx binds BUBR1, impeding the binding of BUBR1 to CDC20 and forming the MCC, causing deregulated APC/C
and subsequent aneuploidy. (c) HCV NS5A disrupts mitotic progression with decreased cyclin B1 and securin degradation. (d) SAC
genes are upregulated in the presence of EBV, potentially inducing genomic instability. Abbreviations: Ad, adenovirus; APC/C,
anaphase-promoting complex/cyclosome; E4orf4, early region 4 open reading frame 4; EBV, Epstein-Barr virus; HBV, hepatitis B virus;
HCV, hepatitis C virus; MCC, mitotic checkpoint complex; NS5A, nonstructural protein 5A; PP2A, protein phosphatase 2A; SAC,
spindle assembly checkpoint.
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Manipulation of the SAC by oncoviruses. (a) HPV E2 binds CDC20, BUBR1, and MAD2, potentially forming an E2-MCC complex
that prevents SAC inactivation; subsequently APC/C activity is impeded, causing mitotic arrest. (b) HPV E5 interacts with BUBR1 and
MAD2, decreasing BUBR1 and MAD2 levels. (c) HPV E6/E7 causes elevated cyclin B1 levels, enabling circumvention of the G2
damage checkpoint and mitosis entry and elevating CDC20 and UBCH10 levels with impulsive APC/C activation and subsequent SAC
inactivation and mitotic exit. Abbreviations: APC/C, anaphase-promoting complex/cyclosome; HPV, human papillomavirus; MCC,
mitotic checkpoint complex; SAC, spindle assembly checkpoint.
example, retrovirus human T cell lymphotropic virus type 1 (HTLV-1), the etiological agent of
aggressive leukemia adult T cell leukemia/lymphoma, targets cell cycle progression control to
sustain viral replication and stimulate infected T cell proliferation (Boxus &Willems 2009).
The influence of Tax protein on the SAC was first indicated when MAD1 was identified as
a tax interacting partner, which coincided with human MAD1 discovery ( Jin et al. 1998). Tax
binds MAD1 through the same domain required for heterodimerization with MAD2, causing loss
of the mitotic checkpoint (Figure 4a) ( Jin et al. 1998). Further studies of Tax-transformed cells
showed thatMAD1 andMAD2weremislocalized to the cytoplasm,which correlated with a loss of
SAC function and microtubule inhibitor chemoresistance (Kasai et al. 2002). In addition, tax can
manipulate APC/C-CDC20, provoking a delay in cell cycle phases S/G2/Mby directly interacting
and prematurely activating APC/C-CDC20 before the onset of mitosis (Figure 4b).
Kaposi’s sarcoma–associated herpesvirus (KSHV), also known as human herpesvirus 8
(HHV8), expresses latency-associated nuclear antigen (LANA) during latent infection. LANA
interacts in vivo and in vitro with BUB1 (Figure 4c), which is essential for LANA centromeric
localization (Xiao et al. 2010). BUB1 KNL and kinase domains are crucial for LANA-BUB1 in-
teraction (Sun et al. 2014, 2015).Moreover, LANAmediates BUB1 degradation by the ubiquitin-
mediated proteasome degradation pathway through the association of LANA with the APC/C,
which recruits BUB1 to the APC/C for degradation (Sun et al. 2014). It is plausible that this degra-
dation impedes SAC activity with consequential uncontrolled APC/C activity and subsequent
CIN.
Simian virus 40 (SV40) large tumor antigen (LT) is a multifunctional phosphoprotein essential
for driving viral replication and cell cycle dysregulation that causes efficient immortalization and
oncogenic transformation of rodent cells (Cotsiki et al. 2004). LT was shown to induce CIN hall-
marks of micronuclei, lagging chromatin and anaphase bridges, in a BUB1-binding-dependent
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manner (Figure 4d), reflecting SAC disruption (Cotsiki et al. 2004, Hu et al. 2013). Some viruses
targeting the SAC are oncolytic rather than oncogenic, preferentially targeting and infecting tu-
mor cells, resulting in apoptotic death. Adenoviruses (Ads) are double-stranded DNA viruses that
cause diverse clinical illnesses including upper respiratory infections, conjunctivitis, tonsillitis, and
gastroenteritis in mammalian species. Although its oncogenic potential in humans is unknown,
human Ad (HAd) can stimulate cell transformation in tissue culture (Fehr & Yu 2013). HAd en-
codes E4orf4 (early region 4 open reading frame 4), which stimulates a G2/M phase cell cycle
block and induces apoptosis of transformed cells (Mui et al. 2010), dependent on E4orf4 binding
to PP2A (protein phosphatase 2A). The E4orf4-PP2A complex manipulates APC/C activation
(Figure 5a), directly interacting with APC/C to alter its activity (Kornitzer et al. 2001, Mui et al.
2010).
Hepatitis B virus (HBV) is a primary etiological factor for hepatocellular carcinoma (HCC)
development. A high SAC impairment frequency has been illustrated in HCC cell lines exhibit-
ing CIN, and the aneuploidy observed is likely due to a defective SAC (Saeki et al. 2002). HBV
regulatory proteinHBx binds and colocalizes with BUBR1 at kinetochores.TheHBx-binding do-
main and the CDC20-binding domain of BUBR1 overlap; thus,HBx-BUBR1 interaction disrupts
BUBR1’s ability to bind CDC20 and subsequent MCC function by inhibiting APC/C-CDC20
(Figure 5b) (Chae et al. 2013, Kim et al. 2008). However, other investigations have not been able
to confirm that HBx disrupts the SAC and MCC but instead have shown that HBx binds E3
ubiquitin ligase DDB1 (damaged DNA–binding protein 1), which potentially contributes to CIN
(Martin-Lluesma et al. 2008).
Overexpression of hepatitis C virus (HCV) protein NS5A (nonstructural protein 5A) induces
mitotic aberrations including unscheduled delay in mitotic exit and multipolar spindles that are
associated with CIN and aneuploidy (Figure 5c) (Baek et al. 2006). The frequency and extent
of CIN was abnormally high in NS5A-expressing cells, even in the absence of the mitotic cell
cycle dysregulating stimulus nocodazole, indicating that NS5A directly disrupts the timing of
mitotic progression (Baek et al. 2006). NS5A-expressing cells exhibited increased fractions of mi-
totic cells, reducedG1 cell populations, and decreased cyclin B and securin degradation, indicating
that elevated cyclin B and securin levels perturb the normal mitotic cell cycle timing (Baek et al.
2006). Furthermore, HCV infection or expression of the viral core protein alone in various cell
types, including hepatocyte culture and transgenic mice, impededmitotic checkpoint function and
induced chromosomal aberrations including polyploidy, indicating that these effects are likely uni-
versal (Machida et al. 2009).
PLK1 has been identified as a host factor for HCV replication regulation. PLK1 co-
immunoprecipitated and partially colocalized with NS5A and was capable of inducingNS5A basal
phosphorylation and hyperphosphorylation in vitro (Chen et al. 2010). PLK1 inhibition with a
PLK1 inhibitor or knockdown in vivo caused reduced NS5A hyperphosphorylation and HCV
replication, indicating that PLK1 mediates HCV replication regulation through NS5A hyper-
phosphorylation and its potential as an antiviral target for HCV-associated HCC (Chen et al.
2010).
Epstein-Barr virus (EBV) is etiologically implicated in several cancers including Burkitt’s
lymphoma, posttransplant lymphoproliferative disease, nasopharyngeal carcinoma, and AIDS-
associated lymphomas (Carbone et al. 2008). Expression of a subset of EBV genes in Burkitt’s
lymphoma–derived cell lines treated with nocodazole and taxol demonstrated SAC disruption
and mitotic slippage with subsequent mitotic aberrations, polyploidy, and aneuploidy (Leao et al.
2007). Global gene expression profile analysis revealed that the central SAC-related genes PLK1,
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AURORA A,AURORA B,CDC20, BUB1, andMAD2 were upregulated in EBV-transformed lym-
phoblasts (Dai et al. 2012). As EBV-induced aneuploidy has been associated with SAC disruption
(Figure 5d), upregulation of these SAC genes potentially induces genomic instability, lymphocyte
transformation, and aberrant proliferation (Dai et al. 2012).
Human papillomaviruses (HPVs) are small DNA viruses infecting human epithelial skin cells
and the cervix, stimulating hyperproliferative lesions resulting in cervical cancer. Different strains
are categorized into two types: High-risk strains comprise viruses with malignant properties and
are related to cervical cancer, and low-risk strains contain viruses accountable for benign growths.
HPV E2 protein as a viral transcription and replication factor has well-ascertained roles. E2 from
high-risk HPV strains directly interacts with CDC20, disrupts APC/C function, and stimulates a
mitotic block and often subsequent metaphase-specific apoptosis (Bellanger et al. 2005). As HPV
E2 is known to stabilize cyclin B, E2 interactions with MCC proteins (Figure 6a) potentially
prevent SAC inactivation and MCC disassembly at the end of metaphase, resulting in mitotic
arrest (Tan et al. 2015).
Immunoprecipitation analysis has demonstrated that BUB1 and MAD2 interact with HPV E5
and may be implicated in decreasing BUB1 and MAD2 expression (Figure 6b) (Liao et al. 2012).
In E5-transfected cells, BUB1 andMAD2RNA and protein levels were significantly reduced,with
cells exhibiting significantly enhanced proliferation and a greater cell population proportion in S
phase (Liao et al. 2012). These findings indicate that HPV E5 crucially contributes to tumorige-
nesis and could serve as a potential target for cervical cancer therapeutic strategies. HPV E6/E7
gene expression facilitates circumventing the G2 DNA damage checkpoint and the SAC despite
the presence of DNA damage. Elevated cyclin B, CDC20, and UBCH10 levels were observed in
HPV E6/E7-expressing cells (Patel & McCance 2010). It is plausible that elevated cyclin B per-
mits evading the G2DNA damage checkpoint and enables M phase entry, while high CDC20 and
UBCH10 levels cause impulsive APC/C activation and ensuing SAC inactivation, with cyclin B
degraded, allowing mitotic exit and cell cycle progression (Patel &McCance 2010). Furthermore,
HPV E6 expression in noncancerous cells induced lagging chromosomes, multiple chromosomes
associated with one or both spindle poles with subsequent aneuploidy, and dramatic mitotic delay
(Figure 6c) (Shirnekhi et al. 2017).
Despite the fact that viral particles are just beginning to be used as novel tools for studying the
SAC, they could prove instrumental in enhancing our understanding of cell division and regulation
and exploring the prospects of isolating central SAC regulator functions inMCCassembly,APC/C
regulation, andmitotic exit. Future investigations must ascertain the precise mechanisms by which
viral proteins manipulate the SAC and identify all central SAC regulators targeted.
4.3. SAC and Innovative Cancer Therapies
In the past 40 years, cancer treatment techniques, including chemo- and radiotherapy, have not
significantly decreased cancer-related mortality, which is still above 50% of cases. This limited
success is due in part to multiple side effects these therapies cause to normal, surrounding cells,
including the induction of DNA damage that can promote the development of mutations and
neoplastic transformation. This situation has stimulated the search for more specific, efficient,
and widely accessible anticancer therapies. One important focus of research is the signaling and
metabolic pathways implicated in cancer cell biology and tumor progression. Solid tumors are
frequently aneuploid, and many display high rates of chromosome missegregation and CIN. The
most common cause of the latter condition is the persistence of aberrant kinetochore-microtubule
attachments, as shown by the presence of lagging chromosomes in anaphase. The observations
that inhibiting MPS1 with chemical inhibitors kills cultured tumor cells while leaving normal cell
268 Curtis et al.
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Oncogene addiction:
the dependency of
certain tumor cells on
a single activated
oncogenic protein or
signaling pathway to
preserve the
malignancy state
growth unaffected (Daniel et al. 2011, Kwiatkowski et al. 2010) and that its partial inhibition cre-
ates tumor cells more sensitive to clinical doses of taxol ( Janssen et al. 2009) indicate that tumor
cell proliferation can be halted through SAC inhibition (Daniel et al. 2011, Kwiatkowski et al.
2010). However, the incomplete inhibition of the SAC can also have the opposite effect of confer-
ring a growth advantage to cancer cells, enabling them to tolerate aneuploidy and to escape from
apoptosis (Kawakami et al. 2019, Sinha et al. 2019). Furthermore, the ATP-binding competitor
inhibitors of SAC kinases developed to date exhibit relaxed target specificity and cannot truly dif-
ferentiate between cancer and normal cells. For example, theMPS1 inhibitor reversine is a promis-
cuous compound that was first recognized as an inhibitor of aurora B, while the MPS1 inhibitors
NMS-P153 and SP600125 are known to bind to FAK/PTK2A and Janus kinases, respectively
(Schmidt et al. 2005). Therefore, despite sustained efforts by various drug discovery groups in in-
dustry and academia, all of the small inhibitors of aurora and PLK1 kinases reported to date have
failed to demonstrate good therapeutic activity against solid tumors. An alternative strategy cur-
rently being explored is the search of ubiquitin ligase inhibitors that target the E3 ubiquitin ligase
activity of the APC/C complex and APC/C regulators (Henriques et al. 2019, Zhou et al. 2016). In
addition to upstream SAC kinases and downstream ubiquitin ligases, components of this molecular
circuitry with no enzyme activity such as the APC/C activator CDC20may constitute suitable new
drug targets, an idea supported by the reported observations that depletion of CDC20 enhanced
pancreatic cancer cytotoxicity upon paclitaxel treatment and increased the effectiveness of gamma
irradiation (Taniguchi et al. 2008). Although conventional cytotoxic therapies that cause DNA
damage or target cell cycle regulation can induce cell death when checkpoint repair mechanisms
fail (Goldstein&Kastan 2015), the acquisition of defects in one or more checkpoint pathways dur-
ing tumor progression can result in the suboptimal maintenance of genome integrity. This in turn
may open up new therapeutic windows for targeted cancer treatments, including approaches that
exploit synthetic lethality and oncogene addiction (Amin et al. 2015) to reduce dose-limiting tox-
icities to normal cells. For example, mutations that result in the activation of oncogenes or the
loss of certain tumor suppressors can create new vulnerabilities that are cancer cell specific
(Bartkova et al. 2005, Di Micco et al. 2006, Gorgoulis et al. 2005, Halazonetis et al. 2008, Hills
& Diffley 2014). Even though the individual inactivation of one out of two compensatory path-
ways often does not compromise cell viability, the simultaneous disruption of both compensatory
pathways can trigger programmed cell death.
In summary, one downside of chemo- and radiotherapy is that cytotoxicity derived from treat-
ment regimens can increase the extent of mutagenesis in subpopulations of cancer cells that have
already evaded the mechanism of checkpoint control, resulting in even more genetically unsta-
ble, drug-resistant clones. One way to avoid the reemergence of drug-resistant populations is to
use combinations of cytotoxic agents that simultaneously attack different DNA damage response
pathways. The development of new drugs that can interfere with the tension-sensitive nature of
the SAC and its communication with the KMN network in human tumors appears to be an at-
tractive alternative for the selective killing of cells that display CIN. In this regard, one strategy
that remains largely unexplored is the targeting of specific protein-protein interactions in regu-
latory hubs that control chromosome segregation and mitosis progression, which may constitute
an important pool of novel cancer drug targets. Similarly, the comprehensive analysis of protein
expression profiles in different cancer cell lines will be instrumental to define the contribution of
central components of the SAC signaling pathway to chemotherapy drug sensitivity, paving the
way for the rational development of more effective anticancer drugs that function on different lev-
els or involve diverse molecular mechanisms of action (see the sidebar titled Artificial Intelligence,
Chromosome Segregation, and Cancer).
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ARTIFICIAL INTELLIGENCE, CHROMOSOME SEGREGATION, AND CANCER
The enormity of clinical data that oncologists, radiologists, surgeons, and doctors handle proves challenging and
complex for analysis (Rabbani et al. 2018). Artificial intelligence (AI), which ultimately aims to computationally
model human behavior and thinking processes, is gaining momentum in its application for tumor detection, pa-
tient stratification, cancer prognosis, and treatment (Ari & Hanbay 2018, Londhe & Bhasin 2019, Robertson et al.
2018). Recent AI advances and automated capabilities have proved momentous in enhancing clinicians’ qualitative
expertise in translating intratumoral phenotypic attributes to genotype implications and outcome predictions by
allowing researchers to cross-reference individual tumors with databases of potentially limitless comparable cases,
collectively leading to earlier interventions and significant diagnosis and clinical care enhancements (Bi et al. 2019).
These approaches will soon be implemented in the analysis and treatment of aggressive tumors associated with
chromosome segregation defects. AI is currently used in drug discovery programs to aid target identification, drug
design, protein engineering, gene expression analysis, and pharmacodynamics modeling for precision medicine de-
velopment (Chen et al. 2018, Kalinin et al. 2018,Mak & Pichika 2019, Zhang et al. 2017, Zhavoronkov et al. 2019),
but has not yet been fully exploited to identify and validate new drugs designed to target the SAC.
SUMMARY POINTS
1. The spindle assembly checkpoint (SAC) plays a fundamental role in the maintenance
of genome stability by ensuring the timely segregation of the genetic material every
time a cell divides. Despite recent important advances, crucial details of SAC signaling,
including signal initiation and SAC regulation, remain to be fully understood.
2. Diverse types of oncoviruses, ranging from double-stranded DNA parapoxviruses and
papilloma viruses to adenoviruses and retroviruses, harness control of chromosome seg-
regation in human cells.The anaphase-promoting complex/cyclosome (APC/C) appears
to be a preferred viral target for establishing an intracellular environment favoring viral
replication.
3. Defects in the SAC result in cell-specific vulnerabilities that can be exploited for the
treatment of aggressive tumors.
4. Several small-size inhibitors of SAC kinases are currently undergoing clinical trials. Fur-
ther exploration of their use in combination with established cytotoxic agents or radia-
tion biology is needed to develop more effective therapies for the treatment of cancers
of poor prognosis.
FUTURE ISSUES
1. Establishing the underlying SACmutations in a patient’s tumor to identify specific onco-
genic drivers remains of paramount importance.
2. Several important mechanistic aspects underlying the control of chromosome segrega-
tion remain to be clarified, including the definition of the precise role of BUB3 in the
mitotic checkpoint complex (MCC) bound to APC/C-CDC20, and how exactly the var-
ious conformational states of APC/C-CDC20 are regulated in the cell.
270 Curtis et al.
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3. It is equally important to evaluate the global implications that oncoviruses targeting the
SAC exert on cellular metabolism in normal cells and tissue-specific tumors.
4. It seems feasible to target central SAC components alone or when engaged in complex
formation for the treatment of cancer. Strategies based on fragment-based discovery will
be increasingly popular to assess the druggability of the SAC.
5. It remains to be determined whether manipulation of the SAC together with X-ray
irradiation/proton beam therapy can sensitize cancer cells to drugs.
6. The utilization of viral particles for cancer therapeutic strategies that target the SAC-
kinetochore-microtubule axis is yet to be explored.
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